許聰文。1993。豬萎縮性鼻炎粗製巴氏桿菌毒素之免疫原性研究。碩士論文。中興大學獸醫學研究所。台中。中華民國。蘇秀琪。1997。巴氏桿菌毒素生物活性之探討。碩士論文。中興大學獸醫學研究所。台中。中華民國。陳有得。1999。豬萎縮性鼻炎重組巴氏桿菌毒素次單位疫苗之免疫效力試驗。碩士論文。中興大學獸醫學研究所。台中。中華民國。吳誌銘。2001。巴氏桿菌毒素次單位DNA疫苗之免疫效力評估。碩士論文。中興大學獸醫學研究所。台中。中華民國。林佳譓。2003。洛德乳酸桿菌表現分泌植酸酶的研究。中興大學獸醫微生物學學研究所。台中。中華民國。Ackermann M.R., Adams D.A., Gerken L.L., Beckman M.J., Rimler R.B. Purified Pasteurella multocida protein toxin reduces acid phosphatase-positive osteoclasts in the ventral nasal concha of gnotobiotic pigs. Calcif Tissue Int. 1993 Jun; 52:455-459.
Ackermann M.R., Register K.B., Stabel J.R., Gwaltney S.M., Howe T.S., Rimler R.B.. Effect of Pasteurella multocida toxin on physeal growth in young pigs. Am J Vet Res. 1996 Jun; 57:848-852.
Alander M., Korpela R., Saxelin M., Vilpponen-Salmela T., Mattila-Sandholm T., von Wright A.. Recovery of Lactobacillus rhamnosus GG from human colonic biopsies. Lett Appl Microbiol. 1997 May; 24:361-364.
Aleljung P., Shen W., Rozalska B., Hellman U., Ljungh A., Wadstrom T. Purification of collagen-binding proteins of Lactobacillus reuteri NCIB 11951. Curr Microbiol. 1994 Apr; 28:231-236.
Alpert C.A., Crutz-Le Coq A.M., Malleret C., Zagorec M. Characterization of a theta-type plasmid from Lactobacillus sakei: a potential basis for low-copy-number vectors in lactobacilli. Appl Environ Microbiol. 2003 Sep; 69: 5574-5584.
Axelsson L. T., Chung T. C., Dobrogosz W. J., Lindgren S. E. Production of a broad-spectrum antimicrobial substance by Lactobacillus reuteri. Microbial Ecology in Health and Disease. 1989; 2:131-136.
Bergey D. H. & Guibbon N. E. Bergey's Manual of Determinative Bacteriology. Lippincott Williams & Wilkins. Baltimore. USA. 1994.
Bording A., Nymark K., Smidt E. Field trials with a new genetically engineered vaccine for protection against progressive atrophic rhinitis in pigs. Acta Vet Scand. 1994; 35:155-163.
Brown J. P. Role of gut bacterial flora in nutrition and health: a review of recent advances in bacteriological techniques, metabolism, and factors affecting flora composition. CRC Crit Rev Food Sci Nutr. 1977 Jan; 8:229-336.
Chanter N., Rutter J. M., Mackenzie A. Partial purification of an osteolytic toxin from Pasteurella multocida. J Gen Microbiol. 1986 Apr; 132:1089-1097.
Chatel J.M., Langella P., Adel-Patient K., Commissaire J., Wal J.M., Corthier G. Induction of mucosal immune response after intranasal or oral inoculation of mice with Lactococcus lactis producing bovine beta-lactoglobulin. Clin Diagn Lab Immunol. 2001 May; 8: 545-551.
Chung, T. C., Axelsson L. T., Lindgren S. E., and Dobrogosz W. J. In vitro studies on reuterin synthesis by Lactobacillus reuteri. Microbial. Ecology in Health and Disease. 1989; 2:137-144.
Chung, T. C., Pagano G. A., and Dobrogosz W. J. Studies on the distribution of Lactobacillus reuteri in swine gastrointestinal tract. J. Vet. Med. and Ani. Hus.. 1991; 58:1-15.
de Jong, M.F. Progressive atrophic rhinitis. Disease of swine. 7th ed. Wolfe, Ames, Iowa. P. 1992; 414-435.
Dominick M.A., Rimler R.B. Turbinate osteoporosis in pigs following intranasal inoculation of purified Pasteurella toxin: histomorphometric and ultrastructural studies. Vet Pathol. 1988 Jan; 25: 17-27.
Donohue D. C., Salminen S. Safety of probiotic bacteria. Asia Pacific J Clin Nutr. 1996; 5: 25-28.
Dudet L.I., Chailler P., Dubreuil J.D., Martineau-Doize B. Pasteurella multocida toxin stimulates mitogenesis and cytoskeleton reorganization in Swiss 3T3 fibroblasts. J Cell Physiol. 1996 Jul; 168:173-182.
Edens F. W., Parkhurst C. R., Casas I. A., Dobrogosz W. J. Principles of ex ovo competitive exclusion and in ovo administration of Lactobacillus reuteri. Poult Sci. 1997 Jan; 76:179-196.
el-Ziney M. G., Debevere J. M. The effect of reuterin on Listeria monocytogenes and Escherichia coli O157:H7 in milk and cottage cheese. J Food Prot. 1998 Oct; 61:1275-1280.
el-Ziney M. G., van den Tempel T., Debevere J., Jakobsen M. Application of reuterin produced by Lactobacillus reuteri 12002 for meat decontamination and preservation. J Food Prot. 1999 Mar; 62:257-261.
Essler M., Hermann K., Amano M., Kaibuchi K., Heesemann J., Weber P.C., Aepfelbacher M. Pasteurella multocida toxin increases endothelial permeability via Rho kinase and myosin light chain phosphatase. J Immunol. 1998 Nov 15; 161:5640-5646.
Felix R., Genolet C.L., Lowik C., Cecchini M.G., Hofstetter W. Cytokine production by calvariae of osteopetrotic mice. Bone. 1995 Jul; 17:5-9.
Felix R., Fleisch H., Frandsen P.L. Effect of Pasteurella multocida toxin on bone resorption in vitro. Infect Immun. 1992 Dec; 60:4984-4988.
Ganzle M. G., Holtzel A., Walter J., Jung G., Hammes W. P. Characterization of reutericyclin produced by Lactobacillus reuteri LTH2584. Appl Environ Microbiol. 2000 Oct; 66:4325-4333.
Gwaltney S.M., Galvin R.J., Register K.B., Rimler R.B., Ackermann M.R. Effects of Pasteurella multocida toxin on porcine bone marrow cell differentiation into osteoclasts and osteoblasts. Vet Pathol. 1997 Sep; 34:421-430.
Holtzel A., Ganzle M. G., Nicholson G. J., Hammes W. P., Jung G. The First Low Molecular Weight Antibiotic from Lactic Acid Bacteria: Reutericyclin, a New Tetramic Acid. Angew Chem Int Ed Engl. 2000 Aug; 39:2766-2768.
iDali C., Foged N.T., Frandsen P.L., Nielsen M.H., Elling F. Ultrastructural localization of the Pasteurella multocida toxin in a toxin-producing strain. J Gen Microbiol. 1991 May; 137:1067-1071.
Jarvinen L.Z., Hogenesch H., Suckow M.A., Bowersock T.L. Induction of protective immunity in rabbits by coadministration of inactivated Pasteurella multocida toxin and potassium thiocyanate extract. Infect Immun. 1998 Aug; 66:3788-3795.
Kabuki T., Saito T., Kawai Y., Uemura J., Itoh T. Production, purification and characterization of reutericin 6, a bacteriocin with lytic activity produced by Lactobacillus reuteri LA6. Int J Food Microbiol. 1997 Feb; 34:145-156.
Kandler, O., Stetter, K.-O. & Köhl, R. Lactobacillus reuteri sp. nov., a new species of heterofermentative Lactobacilli. Zentbl Bakteriol Mikrobiol Hyg I Abt Orig C1, 1980; 264–269.
Klaenhammer T. R. Bacteriocins of lactic acid bacteria. Biochimie. 1988 Mar; 70:337-349.
Kuroki T., Shingu M., Koshihara Y., Nobunaga M. Effects of cytokines on alkaline phosphatase and osteocalcin production, calcification and calcium release by human osteoblastic cells. Br J Rheumatol. 1994 Mar; 33:224-230.
Lacerda H.M., Lax A.J., Rozengurt E. Pasteurella multocida toxin, a potent intracellularly acting mitogen, induces p125FAK and paxillin tyrosine phosphorylation, actin stress fiber formation, and focal contact assembly in Swiss 3T3 cells. J Biol Chem. 1996 Jan 5; 271:439-445.
Lindgren S. E., Dobrogosz W. J. Antagonistic activities of lactic acid bacteria in food and feed fermentations. FEMS Microbiol Rev. 1990 Sep; 7:149-163.
Messens W., De V. L. Inhibitory substances produced by Lactobacilli isolated from sourdoughs--a review. Int J Food Microbiol. 2002 Jan; 72:31-43.
Morelli L., Cocconcelli P. S., Bottazzi V., Damiani G., Ferretti L., Sgaramella V. Lactobacillus protoplast transformation. Plasmid. 1987 Jan; 17:73-75.
Mullan P.B., Lax A.J. Pasteurella multocida toxin is a mitogen for bone cells in primary culture. Infect Immun. 1996 Mar; 64:959-965.
Nair S.P., Meghji S., Wilson M., Reddi K., White P., Henderson B. Bacterially induced bone destruction: mechanisms and misconceptions. Infect Immun. 1996 Jul; 64:2371-2380.
Nakai T., Kume K. Purification of three fragments of the dermonecrotic toxin from Pasteurella multocida. Res Vet Sci. 1987 Mar; 42:232-237.
Nemcova R., Laukova A., Gancarcikova S., Kastel R. In vitro studies of porcine lactobacilli for possible probiotic use. Berl Munch Tierarztl Wochenschr. 1997 Dec; 110:413-417.
Ohnishi T., Horiguchi Y., Masuda M., Sugimoto N., Matsuda M. Pasteurella multocida toxin and Bordetella bronchiseptica dermonecrotizing toxin elicit similar effects on cultured cells by different mechanisms. J Vet Med Sci. 1998 Mar; 60:301-305.
Oswald E., Sugai M., Labigne A., Wu H.C., Fiorentini C., Boquet P., O'Brien A.D. Cytotoxic necrotizing factor type 2 produced by virulent Escherichia coli modifies the small GTP-binding proteins Rho involved in assembly of actin stress fibers. Proc Natl Acad Sci U S A. 1994 Apr 26; 91:3814-3818.
Petersen S.K., Foged N.T. Cloning and expression of the Pasteurella multocida toxin gene, toxA, in Escherichia coli. Infect Immun. 1989 Dec; 57: 3907-3913.
Pettit R.K., Ackermann M.R., Rimler R.B. Receptor-mediated binding of Pasteurella multocida dermonecrotic toxin to canine osteosarcoma and monkey kidney (vero) cells. Lab Invest. 1993 Jul; 69:94-100.
Reid G., Bruce A. W., McGroarty J. A., Cheng K. J., Costerton J. W. Is there a role for lactobacilli in prevention of urogenital and intestinal infections? Clin Microbiol Rev. 1990 Oct; 3:335-344.
Rosendal S., Frandsen P.L., Nielsen J.P., Gallily R. Pasteurella multocida toxin induces IL-6, but not IL-1 alpha or TNF alpha in fibroblasts. Can J Vet Res. 1995 Apr; 59:154-156.
Roos, S., Aleljung, P., Robert, N., Lee, B., Wadström, T., Lindberg, M. and Jonsson, H. A collagen binding protein from Lactobacillus reuteri is part of an ABC transporter system? FEMS Microbiol Lett. 1996 Oct; 144:33-38.
Rozengurt E., Higgins T., Chanter N., Lax A.J., Staddon J.M. Pasteurella multocida toxin: potent mitogen for cultured fibroblasts. Proc Natl Acad Sci U S A. 1990 Jan; 87:123-127.
Salanitro J. P., Fairchilds I. G., Zgornicki Y. D. Isolation, culture characteristics, and identification of anaerobic bacteria from the chicken cecum. Appl Microbiol. 1974 Apr; 27:678-687.
Sarra P. G., Vescovo M., Fulgoni M. Study on crop adhesion genetic determinant in Lactobacillus reuteri. Microbiologica. 1986 Jul; 9:279-285.
Savage D. C. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol. 1977; 31:107-133.
Seo B., Choy E.W., Maudsley S., Miller W.E., Wilson B.A., Luttrell L.M. Pasteurella multocida toxin stimulates mitogen-activated protein kinase via G(q/11)-dependent transactivation of the epidermal growth factor receptor. J Biol Chem. 2000 Jan 21; 275:2239-2245.
Shin S.J., Bae J.L., Cho Y.W., Lee D.Y., Kim D.H., Yang M.S., Jang Y.S., Yoo H.S. Induction of antigen-specific immune responses by oral vaccination with Saccharomyces cerevisiae expressing Actinobacillus pleuropneumoniae ApxIIA. FEMS Immunol Med Microbiol. 2005 Feb ; 43:155-64.
Shornikova A. V., Casas I. A., Isolauri E., Mykkanen H., Vesikari T. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J Pediatr Gastroenterol Nutr. 1997 Apr; 24:399-404.
Shornikova A. V., Casas I. A., Mykkanen H., Salo E., Vesikari T. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J. 1997 Dec; 16:1103-1107.
Smyth M.G., Pickersgill R.W., Lax A.J. The potent mitogen Pasteurella multocida toxin is highly resistant to proteolysis but becomes susceptible at lysosomal pH. FEBS Lett. 1995 Feb 20; 360:62-66.
Speck M. L., Dobrogosz W. J., Casas I. A. Lactobacillus reuteri in food supplementation. Food Technol. 1993; 47: 90-94.
Sung H. W., Chen C. N., Chang Y., Liang H. F. Biocompatibility study of biological tissues fixed by a natural compound (reuterin) produced by Lactobacillus reuteri. Biomaterials. 2002 Aug; 23:3203-3214.
Sterner-Kock A., Lanske B., Uberschar S., Atkinson M.J. Effects of the Pasteurella multocida toxin on osteoblastic cells in vitro. Vet Pathol. 1995 May; 32:274-279.
Suckow M.A., Bowersock T.L., Nielsen K., Chrisp C.E., Frandsen P.L., Janovitz E.B. Protective immunity to Pasteurella multocida heat-labile toxin by intranasal immunization in rabbits. Lab Anim Sci. 1995 Oct; 45:526-532.
Talarico T. L., Casas I. A., Chung T. C., Dobrogosz W. J. Production and isolation of reuterin, a growth inhibitor produced by Lactobacillus reuteri. Antimicrob Agents Chemother. 1988 Dec; 32:1854-1858.
Talarico T. L., Dobrogosz W. J. Chemical characterization of an antimicrobial substance produced by Lactobacillus reuteri. Antimicrob Agents Chemother. 1989 May; 33:674-679.
Thurston J.R., Rimler R.B., Ackermann M.R., Cheville N.F. Use of rats to compare atrophic rhinitis vaccines for protection against effects of heat-labile protein toxin produced by Pasteurella multocida serogroup D. Vet Immunol Immunopathol. 1992 Jun; 33:155-162.
To H., Someno S., Nagai S. Development of a genetically modified nontoxigenic Pasteurella multocida toxin as a candidate for use in vaccines against progressive atrophic rhinitis in pigs. Am J Vet Res. 2005 Jan; 66:113-118.
van Diemen P.M., de Jong M.F., de Vries Reilingh G., van der Hel P., Schrama JW. Intranasal administration of Pasteurella multocida toxin in a challenge-exposure model used to induce subclinical signs of atrophic rhinitis in pigs. Am J Vet Res. 1994 Jan; 55:49-54.
van Diemen P.M., de Vries Reilingh G., Parmentier H.K. Immune responses of piglets to Pasteurella multocida toxin and toxoid. Vet Immunol Immunopathol. 1994 Jun; 41:307-321.
Vasfi Marandi M., Dubreuil J.D., Mittal K.R.The 32 kDa major outer-membrane protein of Pasteurella multocida capsular serotype D. Microbiology. 1996 Jan; 142 ( Pt 1):199-206.
Vescovo M., Morelli L., Bottazzi V. Drug resistance plasmids in Lactobacillus acidophilus and Lactobacillus reuteri. Appl Environ Microbiol. 1982 Jan; 43:50-56.
Wagner R. D., Pierson C., Warner T., Dohnalek M., Farmer J., Roberts L., Hilty M., Balish E. Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice. Infect Immun. 1997 Oct; 65:4165-4172.
Wagner R. D., Warner T., Roberts L., Farmer J., Balish E. Colonization of congenitally immunodeficient mice with probiotic bacteria. Infect Immun. 1997 Aug; 65:3345-3351.
Ward P.N., Miles A.J., Sumner I.G., Thomas L.H., Lax A.J. Activity of the mitogenic Pasteurella multocida toxin requires an essential C-terminal residue. Infect Immun. 1998 Dec; 66:5636-42.
Wilson B.A., V. G. Ponferrada, J. E. Vallance, and M. Ho. Localization of the Intracellular Activity Domain of Pasteurella multocida Toxin to the N Terminus. Infect. Immun. 1999 Jan; 67:80-87.
Wolf B. W., Wheeler K. B., Ataya D. G., Garleb K. A. Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus. Food Chem Toxicol. 1998 Dec; 36:1085-1094.